ATTENTION/WARNING - NE PAS DÉPOSER ICI/DO NOT SUBMIT HERE

Ceci est la version de TEST de DIAL.mem. Veuillez ne pas soumettre votre mémoire sur ce site mais bien à l'URL suivante: 'https://thesis.dial.uclouvain.be'.
This is the TEST version of DIAL.mem. Please use the following URL to submit your master thesis: 'https://thesis.dial.uclouvain.be'.
 

Evaluation of threats to cash flows from the U.S. prescription drug market.

Lories, Xavier
(2024)

Files

TFE_Xavier_Lories.pdf
  • Open access
  • Adobe PDF
  • 2.96 MB
Download

Details

Supervisors
Cornuel, Eric
Faculty
Louvain School of Management
Degree label
Master [60] en sciences de gestion (horaire décalé)
Abstract
Reception of letters denying access to the American market can be very damaging for a pharmaceutical company. Indeed, such a letter, at best, delays important cash flows and therefore impacts the ability to finance other projects and to meet shareholders expectations. This work, after covering the basic necessary knowledge, considers the sources of risks to the cash flows from the lucrative US market. As the discussions moves forward, it appears that money, time and politics are at the heart of every potential problem.